Cardiovascular Innovations and Applications

19/02/2026

This study builds a bedside including NOAF, age, NYHA class, sodium, platelets, and to predict post-CRT mortality in , showing high accuracy and enabling personalized risk stratification, closer follow-up, and therapy optimization to improve outcomes.

:

A predictive nomogram to improve risk stratification after cardiac resynchronization therapy (CRT) in patients with heart failure.

13/02/2026

Right minithoracotomy for left resection is as safe and effective as median sternotomy, with comparable outcomes and lower postoperative , supporting minimally invasive .

Read :

Comparing sternotomy with right mini-thoracotomy for the removal of cardiac myxomas- a clinical study.

11/02/2026

This review delineates the structural and functional landscape of Pannexin-1 (Panx1) channels, elucidating their dual roles in pathophysiology where ATP-mediated activation provides , while hyperactivation drives myocardial and adverse in complex disease states.

: https://cvia-journal.org/pannexin1-cardiovascular-diseases-review/

04/02/2026

This review emphasizes the clinical urgency of rapid initiation, optimization and adherence to the foundational quadruple therapy for with reduced ejection fraction ( ), underscoring that early implementation of guideline-directed medical therapy ( ) significantly reduces the high risk of early mortality and hospitalization for patients. UF College of Medicine

:

Emphasizing the need for a system-wide reorientation towards rapid initiation, optimization, and adherence to realize the potential of GDMT in heart failure.

03/02/2026

This review summarizes the advancements in (MCG) as a non-invasive, radiation-free diagnostic for , highlighting its role in early detection and its potential to transform cardiology in China.

:

An insightful review on the clinical applications of magnetocardiography in cardiovascular medicine detailing its working, challenges and future prospects.

30/01/2026

Cardiovascular Innovations and Applications proudly recognizes the invaluable contributions of its 2025 reviewers, whose expertise and dedication advance global cardiovascular science.

Reviewer Acknowledgements 2025: https://cvia-journal.org/cardiovascular-innovations-and-applications-reviewer-acknowledgements-2025/

29/01/2026

This Cardiovascular Innovations and Applications - CVIA Journal study finds that cGAS inhibition preserves integrity, reduces / & enhances function, pointing cGAS inhibition as a novel therapeutic approach to improve in CA patients.

:

Cyclic GMP-AMP synthase, cardiac arrest, cardiac dysfunction, return of spontaneous circulatio

23/01/2026

This case report describes a novel 'second valve drag and reposition' technique to successfully rescue a self-expanding aortic valve that migrated into the left ventricle during for pure .

:

Presenting "Second valve drag & reposition"- a novel technique to rescue a self-expanding aortic valve that migrated into the left ventricle

23/01/2026

This study identifies circulating TGM2 as a novel prognostic for , demonstrating that elevated TGM2 levels correlate with disease severity and provide significant predictive value for major adverse cardiac events ( ) in ACS patients. Capital Medical University 首都医科大学

:

This study investigates the association between circulating TGM2 levels and the severity of coronary stenosis in acute coronary syndrome (ACS)

23/01/2026

This study found that levels were dose-dependently associated with increased burden in 952 Chinese patients, indicating that uric acid may serve as an accessible and potential therapeutic target for AF burden assessment.

:

Serum uric acid levels correlate with atrial fibrillation burden in a dose-dependent manner, suggesting UA as a potential biomarker and therapeutic target.

22/01/2026

This Cardiovascular Innovations and Applications - CVIA Journal review shows how disrupted —covering , dynamics, , , and stress responses—fuels oxidative injury, , and lipid buildup in , while MQC‑targeted therapies hold promise.

:

Explore how mitochondrial quality control impacts atherosclerosis development and discover emerging therapies targeting MQC pathways to restore vascular health

20/01/2026

Call for Editorial Board Members!

CVIA invites cardiovascular researchers to help lead its scientific mission. 2-year term starting Apr 2026.

Deadline: Mar 31, 2026.

Apply: https://cvia-journal.org/call-for-editorial-board-members-cardiovascular-innovations-and-applications/